The development and progress of nanomedicine for esophageal cancer diagnosis and treatment-Reference-Cited by-同舟云学术

The development and progress of nanomedicine for esophageal cancer diagnosis and treatment

Published:2022-11 Issue: Volume:86 Page:873-885
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Li Xiaokun^ORCID,Chen Lingmin,Luan Siyuan,Zhou Jianfeng^ORCID,Xiao Xin,Yang Yushang,Mao Chengyi,Fang Pinhao,Chen Longqi,Zeng Xiaoxi,Gao Huile,Yuan Yong^ORCID

Funder

National Natural Science Foundation of China

Department of Science and Technology of Sichuan Province

Sichuan University

Publisher

Elsevier BV

Subject

Cancer Research

Reference128 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018

3. Diagnosis of early-stage esophageal cancer by Raman spectroscopy and chemometric techniques;Ishigaki;Analyst,2016

4. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China;Zhang;J Cancer Res Clin Oncol,2021

5. Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis;Han;Future Oncol,2021

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancement in Inhaled Nano-drug Delivery for Pulmonary, Nasal, and Nose-to-brain Diseases;Current Drug Delivery;2025-01

2. pH/Hypoxia dual-stimuli responsive COF nanocarriers with reversible charge conversions for the accurate tumor-targeting and enhanced anticancer drug delivery;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-11

3. LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling;Epigenomics;2024-09-05

4. Integrating 18 F-FDG PET/CT Radiomics and Body Composition for Enhanced Prognostic Assessment in Patients with Esophageal Cancer;2024-09-03

5. Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias;Current Issues in Molecular Biology;2024-09-02